Clinical Trials Sponsored by Dutch Colorectal Cancer Group

Total 70 results

Dutch Colorectal Cancer Group

Recruiting

Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases (CAIRO5)

Colorectal Cancer | Liver Metastases

Netherlands, Belgium
Dutch Colorectal Cancer Group

Recruiting

Prospective Data Collection Initiative on Colorectal Cancer (PLCRC)

Colorectal Cancer

Netherlands
UMC Utrecht
Dutch Colorectal Cancer Group

Recruiting

Radioembolization in Elderly/ Fragile Patients With mCRC (CAIRO7)

Colorectal Cancer Metastatic

Netherlands
Dutch Colorectal Cancer Group
Hoffmann-La Roche

Completed

The Role of Surgery of the Primary Tumour in Patients With Synchronous Unresectable Metastases of Colorectal Cancer (CAIRO4)

Rectal Cancer | Colon Cancer | Primary Tumour

Netherlands, Denmark
Dutch Colorectal Cancer Group
Nordic Pharma SAS

Completed

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients. (SALTO)

Colorectal Cancer | Metastases

Netherlands
Dutch Colorectal Cancer Group
Sanofi; Roche Pharma AG

Terminated

Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer

Colorectal Cancer | Liver Metastases

Netherlands
Leiden University Medical Center
Dutch Colorectal Cancer Group; Stichting Darmkanker

Not yet recruiting

DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients With Metastatic Colorectal Cancer (DOSAGE)

Colorectal Cancer | Metastatic Cancer | Older Patients | Candidates for Palliative Chemotherapy

Netherlands
Dutch Colorectal Cancer Group
Roche Pharma AG; The Netherlands Cancer Institute

Active, not recruiting

Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)

Gastric Cancer

Netherlands
Dutch Colorectal Cancer Group
Sanofi; Hoffmann-La Roche; Koningin Wilhelmina Fonds

Completed

Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma

Advanced Colorectal Cancer
Dutch Colorectal Cancer Group
Sanofi; Hoffmann-La Roche; Koningin Wilhelmina Fonds

Unknown

Maintenance Treatment Versus Observation After Induction in Advanced Colorectal Carcinoma (CAIRO3)

Colorectal Cancer Metastatic

Netherlands
Dutch Colorectal Cancer Group
Sanofi; Roche Pharma AG; Koningin Wilhelmina Fonds; Immunicon

Completed

Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer

Colorectal Cancer

Netherlands
Erasmus Medical Center
Dutch Cancer Society; Dutch Pancreatic Cancer Group

Recruiting

Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer (PREOPANC-3)

Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Resectable Pancreatic Adenocarcinoma

Netherlands, Sweden, Norway
The Nordic Colorectal Cancer Biomodulation Group

Completed

FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer

Metastatic Colorectal Cancer

Norway
Austrian Breast & Colorectal Cancer Study Group

Completed

Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C

Colon Cancer Stage III

Austria
Austrian Breast & Colorectal Cancer Study Group

Completed

Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal Carcinoma

Colorectal Carcinoma

Austria
Austrian Breast & Colorectal Cancer Study Group

Completed

Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B

Colon Cancer Stage II

Austria
Austrian Breast & Colorectal Cancer Study Group

Completed

Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients

Early Stage Breast Cancer
Austrian Breast & Colorectal Cancer Study Group

Terminated

Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C

Rectal Cancer Dukes B, Dukes C

Austria
Austrian Breast & Colorectal Cancer Study Group
AstraZeneca

Completed

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

Early-stage Breast Cancer
Austrian Breast & Colorectal Cancer Study Group
AstraZeneca

Completed

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

Early-stage Breast Cancer
Multicenter Clinical Study Group of Osaka, Colorectal...

Completed

Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial

Colorectal Cancer

Japan
Multicenter Clinical Study Group of Osaka, Colorectal...

Withdrawn

Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract

Postoperative Complications | Peritonitis

Japan
Austrian Breast & Colorectal Cancer Study Group
Oberösterreichische Krebshilfe

Recruiting

ABCSG C08-Exercise II: Trial of Endurance Exercise Following Adjuvant Chemotherapy for Colorectal Cancer (ABCSG C08)

Colorectal Carcinoma

Austria
Amgen
Austrian Breast and Colorectal Cancer Study Group

Completed

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Breast Cancer

Austria, Sweden
Multicenter Clinical Study Group of Osaka, Colorectal...

Unknown

A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer

Colorectal Cancer

Japan
German Breast Group
Novartis Pharmaceuticals; Austrian Breast & Colorectal Cancer Study Group

Completed

Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy (NATAN)

Breast Cancer

Germany, Austria
UMC Utrecht
Dutch Pancreatic Cancer Group (DPCG)

Enrolling by invitation

Recurrent Disease Detection After Resection of Pancreatic Adenocarcinoma Using a Standardized Surveillance Strategy (RADAR-PANC)

Resectable Pancreatic Ductal Adenocarcinoma | Recurrent Pancreatic Ductal Adenocarcinoma

Netherlands
Austrian Breast & Colorectal Cancer Study Group
AstraZeneca; Novartis Pharmaceuticals

Completed

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

Breast Cancer

Austria, Germany
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche

Terminated

Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy

Rectal Cancer

Austria
UMC Utrecht
Dutch Pancreatic Cancer Group (DPCG)

Enrolling by invitation

Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy (ARCADE)

Recurrent Pancreatic Ductal Adenocarcinoma

Netherlands
Austrian Breast & Colorectal Cancer Study Group
Pharmacia Austria GmbH

Completed

Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane

Breast Cancer

Austria
AstraZeneca
Austrian Breast and Colorectal Cancer Study Group (ABCSG)

Recruiting

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) (CAMBRIA-2)

Breast Cancer, Early Breast Cancer

United States, Spain, Italy, Belgium, Canada, Korea, Republic of, Portugal, France, United Kingdom, China, Germany, Japan, Mexico, Thailand, Australia, Austria, Brazil, Colombia, Taiwan, Malaysia, Philippines, Poland, Romania, Chile, Sw... and more
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche

Completed

Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy

Rectal Cancer

Austria
Karolinska University Hospital
German Breast Group; Austrian Breast & Colorectal Cancer Study Group; Swedish...

Unknown

Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients (PANTHER)

Breast Cancer

Sweden, Germany, Austria
Genentech, Inc.
Breast International Group; SOLTI Breast Cancer Research Group; Austrian Breast...

Completed

A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)

Breast Cancer

United States, United Kingdom, Germany, Australia, Austria, Belgium, Brazil, France, Guatemala, Italy, Korea, Republic of, Panama, Poland, Portugal, Spain, Czechia, Hungary, Mexico, Peru, Switzerland, El Salvador, Chile
Groupe Regional d'Etudes du Cancer Colorectal

Unknown

Combination Chemotherapy in Treating Patients With Colon Cancer

Colorectal Cancer

Belgium
Bispebjerg Hospital
Danish Cancer Society; Nordic Cancer Union; Danish Colorectal Cancer Group

Unknown

Assessment of Frequency of Surveillance After Curative Resection in Patients With Stage II and III Colorectal Cancer

Colorectal Cancer

Denmark
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche; Cephalon

Completed

A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer (ABCSG 32)

Breast Cancer

Austria
Austrian Breast & Colorectal Cancer Study Group
Merck Gesellschaft mbH, Austria

Terminated

A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis (G-LUCAS)

Colorectal Cancer | Steatohepatitis

Austria
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche; Sanofi-Synthelabo

Completed

Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma

Rectal Cancer

Austria
The Netherlands Cancer Institute
Borstkanker Onderzoek Groep; Dutch Cancer Society

Not yet recruiting

DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy

Breast Cancer
Borstkanker Onderzoek Groep
Sanofi; Novartis; Amgen; Dutch Cancer Society

Completed

Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients (NEO-ZOTAC)

Breast Cancer

Netherlands
Leiden University
Fonds NutsOhra; Dutch Colorectal Cancer Group; Innovatiefonds Zorgverzekeraars; Stichting voor Patienten met Kanker aan het Spijsverteringskanaal (SPKS) and other collaborators

Active, not recruiting

A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients (ASPIRIN)

Colon Cancer | Adjuvant Therapy

Netherlands
Maastricht University Medical Center
Maastricht University; Borstkanker Onderzoek Groep; Dutch Cancer Society

Terminated

Omitting Completion Axillary Treatment in Sentinel Node Positive Breast Cancer Patients Undergoing a Mastectomy

Breast Neoplasms

Netherlands
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche; Merck Gesellschaft mbH, Austria

Completed

Preoperative Chemoradiation With Capecitabine and Cetuximab

Rectal Cancer

Austria
Maastricht University Medical Center
Maastricht University; Borstkanker Onderzoek Groep; Dutch Cancer Society

Recruiting

Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy

Breast Neoplasms

Netherlands
Children's Oncology Group
Pfizer; Erasmus Medical Center; Dutch Childhood Oncology Group; Innovative Therapies...

Active, not recruiting

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

Accelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Blastic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome Positive CML

United States
Austrian Breast & Colorectal Cancer Study Group
Sanofi; Hoffmann-La Roche; Amgen; Ebewe Pharma GmbH

Completed

Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer

Breast Cancer

Austria
German Breast Group
Gilead Sciences; ETOP IBCSG Partners Foundation; UNICANCER; Austrian Breast & Colorectal... and other collaborators

Recruiting

Sacituzumab Govitecan in Primary HER2-negative Breast Cancer (SASCIA)

Triple Negative Breast Cancer | HER2-negative Breast Cancer

Spain, France, Germany, Austria, Belgium, Ireland, Italy, Switzerland
Alliance Foundation Trials, LLC.
Pfizer; Breast International Group; NSABP Foundation Inc; Austrian Breast & Colorectal... and other collaborators

Active, not recruiting

PALbociclib CoLlaborative Adjuvant Study (PALLAS)

Breast Cancer

United States, Spain, Italy, Ireland, United Kingdom, Australia, Germany, Japan, Portugal, Taiwan, Canada, Israel, Netherlands, Switzerland, Belgium, Austria, Hungary, Korea, Republic of, Mexico, Poland, Sweden

Clinical Trials Sponsored by Dutch Colorectal Cancer Group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations